₹1.85
(Market cap
₹18 Cr
Revenue (TTM)
₹12 Cr
P/E Ratio
12.1
P/B Ratio
1.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
10.2 %
-
ROCE
14.2 %
-
Industry P/E
27.44
-
EV/EBITDA
8
-
Debt to Equity
0.3
-
Book Value
₹63
-
EPS
₹6.1
-
Face value
10
-
Shares outstanding
1,681,500
6 Years Aggregate
CFO
₹-6.66 Cr
EBITDA
₹6.08 Cr
Net Profit
₹3.96 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
EP Biocomposites
| 1.3 | 5.4 | 6.3 | -12.2 | -17.2 | -- | -- |
|
*
| -- | -- | -- | -- | -- | -- | -- |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
EP Biocomposites
| -47.0 | -8.5 | -0.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
| -1.3 | 28.1 | 69.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
EP Biocomposites
|
105.4 | 17.7 | 12.0 | 1.0 | -- | 10.2 | 12.1 | 1.7 |
| 474.5 | 1,343.8 | 1,053.2 | 91.8 | 11.3 | 10.6 | 17.8 | 1.8 | |
| 235.0 | 309.8 | 71.0 | 8.6 | -- | 28.1 | 18.2 | 6.7 | |
| 350.6 | 726.2 | 557.9 | 15.8 | 2.3 | 3.5 | 36.8 | 1.3 | |
| 433.2 | 835.8 | 48.2 | 22.9 | 56.3 | 21.9 | 36.2 | 7.6 | |
| 180.1 | 309.8 | 102.2 | 18.2 | 25.6 | 12.1 | 17.1 | 2.0 | |
| 1,721.6 | 12,708.0 | 4,265.3 | 378.3 | 9.3 | 16.1 | 33.5 | 5.2 | |
| 270.0 | 617.4 | 149.8 | 8.5 | -- | 13.6 | 43 | 7.0 | |
| 79.7 | 550.8 | 215.9 | 16.5 | 6.2 | 10.9 | 38.7 | 4.1 | |
| 891.3 | 1,603.2 | 545.8 | 53.2 | 14.9 | 18.5 | 30.3 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About EP Biocomposites
Manufacture of other cement and asbestos cement products n.e.c.
-
Incorporated
2020
-
Chairman
--
-
Managing Director
Rajkumar Kamat
-
Headquarters
Bicholim, Goa
-
Website
Looking for more details about EP Biocomposites Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for EP Biocomposites
What is the current share price of EP Biocomposites Ltd Today?
The share price of EP Biocomposites Ltd is ₹105.35 (BSE) as of 15-Jun-2026 IST. EP Biocomposites Ltd has given a return of -17.21% in the last 3 years.
What is the current PB & PE ratio of EP Biocomposites Ltd?
The P/E ratio of EP Biocomposites Ltd is 12.13 times as on 15-Jun-2026, a 56 discount to its peers’ median range of 27.44 times.
The P/B ratio of EP Biocomposites Ltd is 1.67 times as on 15-Jun-2026, a 49 discount to its peers’ median range of 3.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
20.13
|
1.96
|
|
2024
|
20.06
|
2.41
|
|
2023
|
58.81
|
4.03
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of EP Biocomposites Ltd?
The 52-week high and low of EP Biocomposites Ltd are Rs 149.90 and Rs 75.50 as of 21-Jun-2026.
What is the market cap of EP Biocomposites Ltd?
EP Biocomposites Ltd has a market capitalisation of ₹ 18 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in EP Biocomposites Ltd?
Before investing in EP Biocomposites Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.